Progress in childhood cancer has stalled for Blacks and Hispanics, report says
Advances in childhood cancer are a success story in modern medicine. But in the past decade, those…
Category: Medicine
STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data
Rise and shine, everyone, another busy day is on the way. We can tell because…
How do we know Alzheimer’s drugs ‘work’?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Bristol wins U.S. approval for lung cancer drug targeting rare genetic mutation
The Food and Drug Administration on Wednesday approved a new treatment for people with non-small…
Opinion: I worked for CMS. Even I struggle to help family navigate dual eligibility
Three months ago, my aunt Margaret had a stroke. Days before, she was repainting her…
Opinion: What antidepressants are saying 30 years after the publication of ‘Listening to Prozac’
In 1993, I published “Listening to Prozac,” a book that grew out of my clinical…
How the Bad River Tribe flipped the script on the Native American opioid crisis
BAD RIVER RESERVATION, Wis. — Sunlight is streaming through holes in the walls of a…
STAT+: U.K. approves world’s first CRISPR-based medicine, giving greenlight to therapy for sickle cell, thalassemia
LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both…
STAT+: After four patients died of gene therapy, Astellas sees possible explanation — and a way forward
A gene therapy study, halted when four children with a rare neuromuscular disorder died after…
FDA grants approval for first time to a home test for chlamydia and gonorrhea
The Food and Drug Administration granted marketing approval to a home test for chlamydia and…
STAT+: House panel passes PBM reforms, ratcheting up chance for passage
WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug…
STAT+: More drug and device patents were invalidated for bad info than those filed by other industries, analysis finds
The patents on medicines and devices approved by the U.S. Food and Drug Administration were…
STAT+: FDA’s latest reorganization puts a new emphasis on its investigations
WASHINGTON — There’s about to be a new acronym in town. The Food and Drug…
STAT+: House moves to limit so-called gain-of-function research
WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious…
Type 2 diabetes prevention programs can work at large scale, study finds
LONDON — Clinical trials have shown that lifestyle programs — which include diet, exercise, and…
The apparently strong correlation between biotech stocks and the price of eggs, explained
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: To get things done fast at FDA: ‘Don’t tell anybody,’ cancer chief says
WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for…
STAT+: Hospitals say violence against health workers is surging. Tech companies are stepping in to help
One day in early 2020, just weeks before Philadelphia entered lockdown, Thomas Jefferson University’s public…
STAT+: Life scientists’ flight to biotech labs stalls important academic research
Step inside Natasha Sheybani’s office at the University of Virginia, where she runs a bioengineering…
Opinion: Hospital systems have to decide: Do they want to be Apple or Android?
Convenience is rapidly becoming a guiding principle for hospital system strategy and competition. As patients…
Opinion: Listen: The true costs of mediocre insurance plans for medical students
For the many high-achieving perfectionists who enter medical school each year, the stakes of their…
STAT+: UnitedHealth faces class-action lawsuit over algorithmic care denials in Medicare Advantage plans
A class-action lawsuit was filed Tuesday against UnitedHealth Group and a subsidiary alleging that they…
Fresh produce access boosts health outcomes among diabetes patients and those on Medicaid in recent studies
In Stockton, California, almost 60% of the city’s 320,000 residents are prediabetic or living with…
STAT+: ‘I never realized what people go through’: Doctor and former hospital CEO with Stage 4 cancer calls for greater empathy in medicine
PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road…
STAT+: New NIH head says government has fallen behind pharma on clinical trials
WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure”…
What health policies could hitch a ride on a spending bill?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
A letter from the executive editor: STAT’s investigation into a UnitedHealth algorithm
I want to bring your attention to a vitally important investigation STAT has published today. For more…
One-quarter of Americans have little to no confidence in scientists to act in public’s best interests, per report
America’s trust in scientists and positive views of science has continued to decline, according to…
STAT+: Pharmalittle: AMA calls for obesity drug coverage; Covid rebound may be more common with Paxlovid than without
Top of the morning to you. And a fine one it is. Lots of sunshine…
Opinion: Patent buyouts could spur vital innovation in antibiotics, vaccines, and other medical fields
The announcement by the Center for Medicare and Medicaid Services that ten drugs will be…
STAT+: UnitedHealth pushed employees to follow an algorithm to cut off Medicare patients’ rehab care
The nation’s largest health insurance company pressured its medical staff to cut off payments for…
AMA urges coverage of obesity treatments as payers balk at costs
WASHINGTON – The American Medical Association called on insurance companies, employers, and government programs to…
Study suggests Covid rebound is far more common with Paxlovid than without
A small and preliminary study published Monday seems to indicate that patients receiving the drug…
Opinion: Ohio has enshrined the right to an abortion. But major obstacles remain for patients and providers
Last week those of us who work in reproductive health care celebrated a historic victory in Ohio:…
Life expectancy for men in U.S. falls to 73 years — six years less than women, per study
The life expectancy of men in the U.S. is nearly six years shorter than that…
Is there a bigger move being planned at Cigna?
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: Michigan bill that would pare back pharma liability shied law moves closer to enactment
A one-of-a-kind law in Michigan that prevents the state government and residents from suing pharmaceutical…
Novo Nordisk has its sights on becoming a major player in heart disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Former MIT biologist, who lost positions after engaging in a prohibited sexual relationship, accepts new science position in Prague
Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he…
STAT+: Pharmalittle: Wegovy cuts heart attack risk in milestone trial; AstraZeneca prioritizes U.S. for RSV drug amid surge
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
NYU radiologists tackle the challenge of making MRI machines less expensive
How many radiologists does it take to build a working MRI from scratch? New York…
Opinion: Congress must reauthorize the National Advisory Committee for Seniors and Disasters
With the election of Rep. Mike Johnson as speaker of the House, the urgent and…
STAT+: Eli Lilly’s chief scientist on new obesity drug data, gene editing, and a potential new heart drug
PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a…
.jpg)
The U.K. just cleared a drug to prevent breast cancer. U.S. women may not know it’s already an option
The news that the U.K. has approved a preventive drug for post-menopausal women at risk…
STAT+: Novo Nordisk wants to be a cardiovascular company, too, with sights set on inflammation
PHILADELPHIA – Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster…
STAT+: Patients loved Carbon Health’s diabetes program. That couldn’t save it
A diabetes diagnosis was not what Jason had in mind when he set out on…
STAT+: In first test for base editing, Verve’s one-time treatment lowers cholesterol levels in patients
Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered…
STAT+: Anthos stroke drug appears safer than common blood thinner in mid-stage trial
PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding…